KWKai Wang

Kai Wang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Kai Wang has a total of 19 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Diagnostic PANoptosis-related genes in acute kidney injury: bioinformatics, machine learning, and validation

    by Zhen Chen, Xiaogang Wang, Yifan Shao, Kai Wang, Dong Xue

    Acute kidney injury (AKI) is a prevalent and life-threatening condition characterized by abrupt renal function decline and subsequent inflammatory cascades. PANoptosis has emerged as a significant contributor to the pathophysiology of AKI. This research aimed to explore the diagnostic and therapeutic implications of PANoptosis-related genes in AKI. Kidney biopsy transcriptomic expression data were obtained from the GEO database. Differentially expressed genes (DEGs) associated with PANoptosis were identified between AKI and controls. WGCNA identified hub PANoptosis-related genes. PANoptosis scores and immune cell infiltration were calculated by ssGSEA. Machine learning algorithms was used to select feature genes. ROC analysis evaluated their diagnostic performance. Drug-gene interactions were explored. We identified 3460 DEGs between AKI and controls (61 upregulated and 11 downregulated) related to PANoptosis, mainly enriched in cytokine signaling and apoptosis. Eight hub PANoptosis genes were identified. PANoptosis scores were significantly higher in AKI patients (p < 0.001). CASP8, CASP4, SFN, FAS, and CASP1 were selected as feature genes, with CASP8 having the highest AUC at 0.850 in the training set. A nomogram combining these genes demonstrated strong predictive power. Furthermore, these genes were related to immune cell infiltration positively and had potential drug associations. Validation in a renal ischemia-reperfusion injury rat model confirmed the upregulation of CASP8 (p < 0.01), CASP4 (p < 0.001), SFN (p < 0.0001), FAS (p < 0.01), and CASP1 (p < 0.01). Our study identifies PANoptosis-related genes as potential diagnostic markers and therapeutic targets in AKI, highlighting their role in immune dysregulation in AKI.


  • Deficiency of geranylgeranyl biphosphate synthase in kidney tubules causes cystic kidney disease

    by Xiaoyan Shao, Kai Wang, Jing Wu, Xiaopen Ma, Yinjuan Zhao, Tao Xu, Chunsun Dai, Furong Zhang, Yuqi Wang, Xianguo Ren, et al.

    Polycystic kidney disease (PKD) is a common hereditary kidney disease. Although PKD occurrence is associated with certain gene mutations, its onset regulatory mechanisms are still not well understood. Here, we first report that the key enzyme geranylgeranyl diphosphate synthase (GGPPS) is specifically expressed in renal tubular epithelial cells of mouse kidneys. We aimed to explore the role of GGPPS in PKD. In this study, we established a Ggpps fl/fl :Cdh16 cre mouse model and compared its phenotype with that of wild‐type mice. A Ggpps ‐downregulation HK2 cell model was also used to further determine the role of GGPPS. We found that GGPPS was specifically expressed in renal tubular epithelial cells of mouse kidneys. Its expression also increased with age. Low GGPPS expression was observed in human ADPKD tissues. In the Ggpps fl/fl :Cdh16 cre mouse model, Ggpps deletion in renal tubular epithelial cells induced the occurrence and development of renal tubule cystic dilation and caused the death of mice after birth due to abnormal renal function. Enhanced proliferation of cyst‐lining epithelial cells was also observed after the knockout of Ggpps . These processes were related to the increased rate of Rheb on membrane/cytoplasm and hyperactivation of mTORC1 signaling. In conclusion, the deficiency of GGPPS in kidney tubules induced the formation of renal cysts. It may play a critical role in PKD pathophysiology. A novel therapeutic strategy could be designed according to this work.